IDO1
Reaktivität: Human
WB, ELISA, IF
Wirt: Maus
Monoclonal
1C5
unconjugated
Applikationshinweise
Western Blot (1:1000) Immunohistochemsitry (1:10-50) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Maghzal, Thomas, Hunt, Stocker: "Cytochrome b5, not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells." in: The Journal of biological chemistry, Vol. 283, Issue 18, pp. 12014-25, (2008) (PubMed).
Chauhan, Basran, Efimov, Svistunenko, Seward, Moody, Raven: "The role of serine 167 in human indoleamine 2,3-dioxygenase: a comparison with tryptophan 2,3-dioxygenase." in: Biochemistry, Vol. 47, Issue 16, pp. 4761-9, (2008) (PubMed).
Scheler, Wenzel, Tüting, Takikawa, Bieber, von Bubnoff: "Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?" in: The American journal of pathology, Vol. 171, Issue 6, pp. 1936-43, (2007) (PubMed).